4-Bromopyrazolo[1,5-a]pyridine

Catalog No.: 
ACICOF721
CAS No.: 
1427404-87-2
Molecular Formula: 
C7H5BrN2
Molecular Weight: 
197.04
4-Bromopyrazolo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$53.00In stockIn stock
1g95%$116.00In stockIn stock
5g95%$496.00In stockIn stock
25g95%$2306.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromopyrazolo[1,5-a]pyridine
IUPAC Name4-bromopyrazolo[1,5-a]pyridine
MDL No.MFCD23710563
Molecular FormulaC7H5BrN2
Molecular Weight197.04
SMILESBrC1C2=CC=NN2C=CC=1
InChI KeyCVKNKNVZHOMOHD-UHFFFAOYSA-N
SynonymSCHEMBL20265768 | CS-16707 | SY057618 | 4-Bromo-pyrazolo[1,5-a]pyridine | 4-Bromopyrazolo[1,5-a]pyridine | CS-0102575 | AKOS023630449 | D72087 | MFCD23710563 | CHC40487 | SB33576 | 4-bromo-pyrazolo[2,3-a]pyridine | 1427404-87-2 | EN300-1609067
CAS No.1427404-87-2
PubChem CID83880015

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACICOF721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACICOF721 route product structure diagram
    ACICOF7211427404-87-2In Stock
Inquiry

2. ACICOF721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACICOF721 route product structure diagram
    ACICOF7211427404-87-2In Stock
Inquiry

3. ACICOF721 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACICOF721 route product structure diagram
    ACICOF7211427404-87-2In Stock
Inquiry

Comments (0)